Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Deciphera Pharmaceuticals Inc. (DCPH)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Redmile Group

Jeremy Green

4,978,941 $297,342 -3% 5.48%
2.
VenBio Select Advisor

Kurt Von Emster

1,860,000 $111,079 -8% 2.19%
3.
OrbiMed Advisors

Samuel Isaly

1,125,700 $67,227 -3% 0.94%
4.
Farallon Capital

Thomas Steyer

715,000 $42,700 -29% 0.35%
5.
Alkeon Capital Management

Panayotis Takis Sparaggis

670,975 $40,071 +18% 0.1%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.00 375,000 Large Shareholder 2,146,308 2017-10-02 Filing
$17.00 375,000 Large Shareholder, Director 2,146,308 2017-10-02 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$50.01 3,000 Officer 7,040 2020-09-14 Filing
$47.71 3,000 Officer 7,040 2020-09-10 Filing
$46.55 1,500 Officer 7,040 2020-09-08 Filing
$45.23 3,700 Officer 8,540 2020-09-08 Filing
$44.69 800 Officer 12,240 2020-09-08 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 270,713 $16,166,980 0%
2. 4,705 $280,983 0%
3. 3,549,561 $211,980 0%
4. 3,089,206 $184,488 0%
5. 3,531,488 $175,339 0.09%
News See All